Ruminant Respiratory Disease: Diagnosis and Treatment Protocols
This article provides veterinarians with diagnostic and treatment guidance for respiratory diseases in cattle, sheep, and goats. Respiratory disease remains a leading cause of morbidity, mortality, and economic loss in ruminant production systems worldwide. The content covers bovine respiratory disease (BRD), ovine pneumonia, caprine respiratory infections, and lungworm, with emphasis on clinical diagnosis, treatment protocols, and prevention strategies. All recommendations are based on published veterinary literature and official sources.
At a Glance: Ruminant Respiratory Disease Overview
| Condition | Primary Species | Common Pathogens | Key Clinical Signs | Diagnostic Approach |
|---|---|---|---|---|
| Bovine Respiratory Disease (BRD) | Cattle | Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Mycoplasma bovis, BRSV, PI-3, BHV-1 | Fever, nasal discharge, cough, tachypnea, depression, reduced feed intake | Clinical scoring (DART, Wisconsin), thoracic ultrasound, nasopharyngeal swab culture/PCR, postmortem examination |
| Ovine Pneumonia | Sheep | Mannheimia haemolytica, Pasteurella multocida, Mycoplasma ovipneumoniae, Bibersteinia trehalosi, Ovine adenovirus | Fever, nasal discharge, cough, dyspnea, sudden death in lambs | Clinical examination, nasopharyngeal swab culture/PCR, thoracic ultrasound, postmortem examination |
| Caprine Respiratory Infection | Goats | Mycoplasma ovipneumoniae, Mannheimia haemolytica, Pasteurella multocida, Escherichia coli, lungworms | Cough, nasal discharge, dyspnea, weight loss, reduced milk production | Clinical examination, fecal Baermann for lungworm, nasopharyngeal swab culture/PCR, thoracic ultrasound |
| Lungworm (Dictyocaulus, Muellerius, Protostrongylus) | Sheep, Goats, Cattle | Dictyocaulus viviparus (cattle), Dictyocaulus filaria (sheep/goats), Muellerius capillaris (sheep/goats) | Cough, tachypnea, dyspnea, weight loss, reduced exercise tolerance | Fecal Baermann examination, clinical signs, postmortem examination |
Clinical Diagnosis of Respiratory Disease in Ruminants
History and Signalment
Accurate diagnosis begins with a thorough history and signalment. Record the species, breed, age, sex, and production class (dairy, beef, feedlot, pasture, housed). Note the number of animals affected, duration of clinical signs, recent introductions, vaccination history, and any previous treatments. Environmental factors such as ventilation, stocking density, bedding quality, and recent weather changes are critical. The Merck Veterinary Manual provides comprehensive guidance on history-taking for respiratory disease in ruminants.
Clinical Examination
Perform a systematic clinical examination. Observe the animal from a distance before handling. Record respiratory rate and pattern, presence and character of nasal discharge (serous, mucopurulent, hemorrhagic), cough (spontaneous or induced), and ocular discharge. Assess body temperature, heart rate, and rumen fill. Auscultate the thorax for abnormal lung sounds (crackles, wheezes, pleural friction rubs) and assess for dullness on percussion. In calves, thoracic ultrasound can detect consolidation and pleural effusion. The Veterinary Clinics of North America: Food Animal Practice published a review on bovine respiratory disease diagnosis that discusses clinical scoring systems and diagnostic progress.
Clinical Scoring Systems
Standardized clinical scoring systems improve diagnostic accuracy and consistency. The Wisconsin Calf Respiratory Scoring System uses five categories: rectal temperature, cough, nasal discharge, eye discharge, and ear position. Each category is scored 0 to 3, with a total score of 5 or higher indicating BRD. The DART (Depression, Appetite, Respiration, Temperature) system is used in feedlot cattle. These systems help identify affected animals early and reduce subjectivity. A systematic review in the Journal of Veterinary Diagnostic Investigation examined biomarkers as aids in early diagnosis and outcome prediction of BRD in feedlot cattle.
Diagnostic Imaging
Thoracic ultrasound is a practical tool for detecting lung consolidation, abscesses, and pleural effusion in ruminants. It is particularly useful in calves and small ruminants. Ultrasound findings correlate with postmortem lesions and can guide treatment decisions. Radiography is less commonly used in field settings but may be helpful in individual animals, especially goats and sheep with chronic respiratory disease.
Laboratory Diagnostics
Laboratory confirmation is essential for targeted treatment and antimicrobial stewardship. Collect nasopharyngeal swabs, bronchoalveolar lavage fluid, or transtracheal wash samples for bacterial culture and antimicrobial susceptibility testing. PCR panels can detect viral and bacterial pathogens, including BRSV, PI-3, BHV-1, BVDV, Mycoplasma bovis, and Histophilus somni. Serology is useful for herd-level diagnosis but less helpful for individual acute cases. The Veterinary Clinics of North America: Food Animal Practice published a review on laboratory and postmortem diagnosis of bovine respiratory disease.
Postmortem Examination
Postmortem examination is critical for confirming diagnosis and identifying pathogens. Examine the upper and lower respiratory tract. Note the distribution and character of lesions: cranioventral consolidation (typical of bacterial bronchopneumonia), diffuse interstitial pneumonia (viral), or verminous pneumonia (lungworm). Collect lung tissue, tracheal swabs, and lymph nodes for culture, PCR, and histopathology. The World Organisation for Animal Health provides guidelines for animal health surveillance and disease diagnosis.
Bovine Respiratory Disease (BRD)
Etiology and Pathogenesis
BRD is a multifactorial disease complex involving viral and bacterial pathogens, host factors, and environmental stressors. Common viral agents include bovine respiratory syncytial virus (BRSV), parainfluenza-3 virus (PI-3), bovine herpesvirus-1 (BHV-1, cause of infectious bovine rhinotracheitis), and bovine viral diarrhea virus (BVDV). Bacterial pathogens include Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. The Veterinary Clinics of North America: Food Animal Practice published a review on bovine respiratory coronavirus as a contributing agent.
Stress factors such as weaning, transport, commingling, castration, dehorning, and poor ventilation impair host immunity and predispose to disease. Viral infection damages respiratory epithelium, allowing bacterial colonization and proliferation. The resulting bronchopneumonia is typically cranioventral in distribution.
Clinical Signs
Clinical signs of BRD include fever (rectal temperature >39.5°C), depression, reduced feed intake, nasal discharge (serous to mucopurulent), cough, tachypnea, dyspnea, and ocular discharge. In feedlot cattle, early detection relies on daily observation by trained pen riders. Affected animals may be isolated from the group, have droopy ears, and show abdominal breathing. The Veterinary Clinics of North America: Food Animal Practice published a review on BRD considerations in young dairy calves.
Diagnosis
Diagnosis is based on clinical signs, clinical scoring, thoracic ultrasound, and laboratory confirmation. Nasopharyngeal swabs or bronchoalveolar lavage samples should be submitted for bacterial culture, antimicrobial susceptibility testing, and PCR. Postmortem examination with lung culture and histopathology confirms the diagnosis and identifies pathogens. A systematic review in the Veterinary Clinics of North America: Food Animal Practice focused on diagnostic confirmation, early detection, and prediction of unfavorable outcomes in feedlot cattle.
Treatment Protocols
Treatment of BRD requires antimicrobial therapy, supportive care, and management of environmental stressors. Antimicrobial selection should be based on culture and susceptibility results when possible. Commonly used antimicrobial classes include florfenicol, tulathromycin, ceftiofur, oxytetracycline, and tilmicosin. The choice depends on the pathogen, severity of disease, withdrawal period, and cost. Supportive care includes nonsteroidal anti-inflammatory drugs (NSAIDs) for fever and inflammation, fluid therapy for dehydrated animals, and provision of clean water and palatable feed.
Treatment protocols should include:
- Identify and isolate affected animals.
- Administer antimicrobial therapy according to label directions and veterinary prescription.
- Provide NSAIDs for fever and inflammation.
- Ensure access to clean water and high-quality feed.
- Monitor response to treatment within 48 to 72 hours.
- Retreat animals that do not respond or relapse.
- Record all treatments, including drug, dose, route, date, and withdrawal period.
Prevention and Control
Prevention of BRD relies on reducing stress, optimizing nutrition, and implementing vaccination programs. Vaccines are available for viral pathogens (BRSV, PI-3, BHV-1, BVDV) and bacterial pathogens (Mannheimia haemolytica, Pasteurella multocida, Histophilus somni). Vaccination protocols should be tailored to the herd's risk profile and administered according to label directions. Biosecurity measures include quarantine of new arrivals, all-in/all-out management, and proper ventilation in housing facilities. The Merck Veterinary Manual provides detailed vaccination recommendations for cattle.
Ovine Pneumonia
Etiology and Pathogenesis
Ovine pneumonia is commonly caused by Mannheimia haemolytica, Pasteurella multocida, Bibersteinia trehalosi, and Mycoplasma ovipneumoniae. Viral agents such as ovine adenovirus, parainfluenza-3 virus, and respiratory syncytial virus can predispose to bacterial pneumonia. Stress factors including weaning, transport, crowding, and poor ventilation increase susceptibility. Mycoplasma ovipneumoniae is a primary pathogen in sheep and goats, causing chronic cough and reduced growth rates.
Clinical Signs
Clinical signs include fever, nasal discharge, cough, tachypnea, dyspnea, depression, and reduced feed intake. In lambs, acute pneumonia can cause sudden death. Chronic cases present with poor growth, chronic cough, and exercise intolerance. Thoracic auscultation reveals crackles and wheezes in affected lung fields.
Diagnosis
Diagnosis is based on clinical signs, thoracic ultrasound, and laboratory confirmation. Nasopharyngeal swabs or bronchoalveolar lavage samples should be submitted for bacterial culture, antimicrobial susceptibility testing, and PCR. Fecal Baermann examination is indicated if lungworm is suspected. Postmortem examination with lung culture and histopathology confirms the diagnosis.
Treatment Protocols
Treatment of ovine pneumonia follows similar principles to BRD. Antimicrobial therapy should be based on culture and susceptibility results. Commonly used antimicrobials include oxytetracycline, florfenicol, tulathromycin, and ceftiofur. Supportive care includes NSAIDs, fluid therapy, and provision of clean water and palatable feed. Treatment protocols should include identification and isolation of affected animals, administration of antimicrobial therapy, monitoring response, and recording all treatments.
Prevention and Control
Prevention of ovine pneumonia focuses on reducing stress, optimizing nutrition, and implementing vaccination programs. Vaccines for Mannheimia haemolytica and Pasteurella multocida are available for sheep. Biosecurity measures include quarantine of new arrivals, all-in/all-out management, and proper ventilation in housing facilities. Control of lungworm through pasture management and anthelmintic treatment reduces the risk of verminous pneumonia.
Caprine Respiratory Infection
Etiology and Pathogenesis
Caprine respiratory infections are caused by a range of pathogens including Mycoplasma ovipneumoniae, Mannheimia haemolytica, Pasteurella multocida, and Escherichia coli. Mycoplasma ovipneumoniae is a primary pathogen in goats, causing chronic cough, reduced growth rates, and increased susceptibility to secondary bacterial infections. A study in BMC Microbiology characterized the pathogenic characteristics, population structure, and genomic features of Mesomycoplasma ovipneumoniae from goats with respiratory infection. Escherichia coli has been identified as a pathogen in goats with respiratory disease, with molecular characterization and antimicrobial resistance profiles reported in a study from eastern China published in Microbial Pathogenesis.
Clinical Signs
Clinical signs include cough, nasal discharge, dyspnea, tachypnea, weight loss, reduced milk production, and depression. Chronic cases present with persistent cough, poor body condition, and exercise intolerance. Acute cases may present with fever and severe dyspnea. Thoracic auscultation reveals crackles and wheezes.
Diagnosis
Diagnosis is based on clinical signs, thoracic ultrasound, and laboratory confirmation. Nasopharyngeal swabs or bronchoalveolar lavage samples should be submitted for bacterial culture, antimicrobial susceptibility testing, and PCR. Fecal Baermann examination is indicated if lungworm is suspected. Postmortem examination with lung culture and histopathology confirms the diagnosis.
Treatment Protocols
Treatment of caprine respiratory infections requires antimicrobial therapy, supportive care, and management of environmental stressors. Antimicrobial selection should be based on culture and susceptibility results. A study in Veterinary Microbiology examined antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates. Commonly used antimicrobials include oxytetracycline, florfenicol, tulathromycin, and ceftiofur. Supportive care includes NSAIDs, fluid therapy, and provision of clean water and palatable feed.
Prevention and Control
Prevention of caprine respiratory infections focuses on reducing stress, optimizing nutrition, and implementing vaccination programs. Vaccines for Mannheimia haemolytica and Pasteurella multocida are available for goats. Biosecurity measures include quarantine of new arrivals, all-in/all-out management, and proper ventilation in housing facilities. Control of lungworm through pasture management and anthelmintic treatment reduces the risk of verminous pneumonia.
Lungworm in Ruminants
Etiology and Pathogenesis
Lungworm infections in ruminants are caused by Dictyocaulus viviparus in cattle, Dictyocaulus filaria in sheep and goats, and Muellerius capillaris and Protostrongylus species in sheep and goats. Adult worms reside in the airways, causing bronchitis, bronchiolitis, and verminous pneumonia. Larvae are shed in feces and develop on pasture. Infection occurs through ingestion of third-stage larvae. The Merck Veterinary Manual provides detailed information on lungworm infections in ruminants.
Clinical Signs
Clinical signs include cough, tachypnea, dyspnea, weight loss, reduced exercise tolerance, and reduced milk production. In severe cases, respiratory distress and death can occur. Chronic infections cause persistent cough and poor growth. Thoracic auscultation reveals crackles and wheezes.
Diagnosis
Diagnosis is based on clinical signs, history of pasture exposure, and fecal Baermann examination. The Baermann technique is the standard method for detecting lungworm larvae in feces. Postmortem examination reveals adult worms in the airways and characteristic lung lesions.
Treatment Protocols
Treatment of lungworm infections requires anthelmintic therapy. Commonly used anthelmintics include ivermectin, doramectin, moxidectin, and fenbendazole. The choice depends on the species, severity of infection, and withdrawal period. Supportive care includes NSAIDs for inflammation and provision of clean water and palatable feed.
Prevention and Control
Prevention of lungworm infections focuses on pasture management, anthelmintic treatment, and biosecurity. Avoid overgrazing and practice rotational grazing to reduce pasture contamination. Treat new arrivals with anthelmintics and quarantine before introduction to the herd. Implement a strategic anthelmintic program based on local epidemiology and fecal monitoring.
Antimicrobial Stewardship in Respiratory Disease Treatment
Importance of Culture and Susceptibility Testing
Antimicrobial stewardship is critical in ruminant respiratory disease management. Culture and antimicrobial susceptibility testing should be performed whenever possible to guide treatment decisions. Empirical therapy should be based on local susceptibility patterns and adjusted when results are available. The Veterinary Clinics of North America: Food Animal Practice published a review on laboratory and postmortem diagnosis of bovine respiratory disease that emphasizes the importance of culture.
Withdrawal Periods
All antimicrobials have established withdrawal periods for meat and milk. Veterinarians must ensure that treated animals are not sent to slaughter or milk is not used for human consumption until the withdrawal period has elapsed. Record all treatments, including drug, dose, route, date, and withdrawal period. The World Organisation for Animal Health provides guidelines for responsible antimicrobial use in animals.
Resistance Monitoring
Antimicrobial resistance is a growing concern in ruminant respiratory pathogens. Monitor local resistance patterns through routine culture and susceptibility testing. Report resistance findings to relevant authorities. Implement biosecurity and management practices to reduce the need for antimicrobial therapy.
Records and Measurements
Treatment Records
Maintain accurate treatment records for all animals treated for respiratory disease. Records should include:
- Animal identification (ear tag, tattoo, or other unique identifier)
- Date of treatment
- Clinical signs and diagnostic findings
- Drug name, dose, route, and frequency
- Withdrawal period for meat and milk
- Response to treatment (improved, no change, worsened)
- Retreatment dates and outcomes
Herd-Level Monitoring
Monitor herd-level respiratory disease incidence, prevalence, and mortality. Calculate morbidity and mortality rates for each production group. Track treatment success rates and relapse rates. Use this data to evaluate the effectiveness of prevention and control programs.
Diagnostic Records
Record all diagnostic test results, including culture, susceptibility, PCR, and serology. Maintain postmortem examination reports. Use this data to identify pathogen trends and adjust vaccination and treatment protocols.
Common Failure Patterns
Delayed Diagnosis
Delayed diagnosis is a common cause of treatment failure. Clinical signs may be subtle in early stages, especially in feedlot cattle. Implement daily observation by trained personnel and use clinical scoring systems to detect affected animals early. The systematic review in the Journal of Veterinary Diagnostic Investigation examined biomarkers for early diagnosis of BRD.
Inappropriate Antimicrobial Selection
Inappropriate antimicrobial selection can result from empirical therapy without culture and susceptibility testing. Resistance patterns vary by region and production system. Submit samples for culture and susceptibility testing whenever possible. Adjust empirical protocols based on local resistance data.
Inadequate Duration of Therapy
Inadequate duration of therapy can lead to treatment failure and relapse. Follow label directions for duration of therapy. Monitor response to treatment and extend therapy if clinical signs persist. Retreat animals that relapse.
Environmental Stressors
Environmental stressors such as poor ventilation, high stocking density, and poor nutrition can impair immune function and reduce treatment success. Address environmental factors as part of the treatment plan. Improve ventilation, reduce stocking density, and provide clean water and high-quality feed.
Concurrent Disease
Concurrent disease such as parasitism, nutritional deficiencies, or other infections can complicate respiratory disease treatment. Perform a thorough clinical examination and diagnostic workup to identify concurrent conditions. Treat underlying conditions as part of the overall management plan.
Welfare and Safety Context
Animal Welfare
Respiratory disease causes significant pain and distress in ruminants. Clinical signs such as dyspnea, cough, and fever indicate compromised welfare. Prompt diagnosis and treatment are essential to minimize suffering. Provide supportive care including NSAIDs for pain and inflammation, fluid therapy for dehydrated animals, and provision of clean water and palatable feed. The World Organisation for Animal Health provides standards for animal welfare in livestock production.
Human Safety
Some respiratory pathogens are zoonotic. Mannheimia haemolytica and Pasteurella multocida can cause wound infections in humans. Use appropriate personal protective equipment (gloves, masks, eye protection) when handling affected animals and collecting diagnostic samples. Practice good hygiene and hand washing after animal contact.
Regulatory Compliance
All antimicrobial use must comply with local regulations. Prescription-only antimicrobials require a veterinary-client-patient relationship. Maintain accurate treatment records and adhere to withdrawal periods. The World Organisation for Animal Health provides guidelines for antimicrobial use in animals.
Professional Escalation Criteria
Urgent Veterinary Escalation
Contact a veterinarian immediately if:
- Multiple animals are affected with severe respiratory signs (dyspnea, open-mouth breathing, cyanosis)
- Mortality rate exceeds 2% in a group
- Treatment failure occurs in more than 20% of treated animals
- Suspected foreign body or aspiration pneumonia
- Suspected contagious disease (e.g., contagious caprine pleuropneumonia, malignant catarrhal fever)
- Animals are not responding to initial therapy within 48 hours
Routine Veterinary Escalation
Schedule a veterinary consultation if:
- Respiratory disease incidence exceeds 10% in a group
- Relapse rate exceeds 15% in treated animals
- Chronic cough persists in a group
- Diagnostic testing is needed to identify pathogens
- Vaccination protocols need review
- Antimicrobial resistance is suspected
Practical Decision Framework for Respiratory Disease Management in Ruminants
Treatment Decision Algorithm Based on Clinical Severity and Diagnostic Findings
A structured decision framework helps veterinarians and producers make consistent, evidence-based treatment choices for respiratory disease in ruminants. The algorithm below integrates clinical severity assessment, diagnostic results, and response monitoring to guide antimicrobial selection and supportive care decisions. This framework is adapted from principles described in the Veterinary Clinics of North America Food Animal Practice review on bovine respiratory disease diagnosis.
Step 1: Initial Clinical Severity Classification
Classify each affected animal into one of three severity categories based on clinical examination findings:
Mild Disease
- Rectal temperature 39.5 to 40.5 degrees Celsius
- Mild depression with normal appetite
- Serous nasal discharge
- Occasional cough
- Respiratory rate 30 to 50 breaths per minute
- Normal rumen fill
- No thoracic auscultation abnormalities
Moderate Disease
- Rectal temperature 40.5 to 41.5 degrees Celsius
- Moderate depression with reduced appetite
- Mucopurulent nasal discharge
- Frequent cough
- Respiratory rate 50 to 70 breaths per minute
- Reduced rumen fill
- Crackles or wheezes on thoracic auscultation
- Thoracic ultrasound shows consolidation less than 3 centimeters depth
Severe Disease
- Rectal temperature above 41.5 degrees Celsius
- Severe depression with no appetite
- Purulent or hemorrhagic nasal discharge
- Spontaneous painful cough
- Respiratory rate above 70 breaths per minute
- Abdominal breathing or open-mouth breathing
- Absent rumen fill
- Dullness on thoracic percussion
- Thoracic ultrasound shows consolidation greater than 3 centimeters depth or pleural effusion
Step 2: Diagnostic Sampling Decision
For mild cases in a group with known pathogen history, empirical therapy may be appropriate. For moderate and severe cases, collect diagnostic samples before initiating treatment:
- Nasopharyngeal swab for bacterial culture and antimicrobial susceptibility testing
- Nasopharyngeal swab for respiratory pathogen PCR panel
- Bronchoalveolar lavage if feasible and indicated
- Fecal sample for Baermann examination if lungworm is suspected
- Blood sample for acute phase protein analysis if available
The systematic review in the Journal of Veterinary Diagnostic Investigation examined biomarkers as aids in early diagnosis and outcome prediction of bovine respiratory disease complex in feedlot cattle.
Step 3: Antimicrobial Selection Protocol
Select antimicrobial therapy based on severity classification and available diagnostic information:
Mild Disease Empirical Protocol
- First-line options: oxytetracycline or florfenicol
- Duration: 3 to 5 days
- Reassess at 48 hours
Moderate Disease Empirical Protocol
- First-line options: tulathromycin or ceftiofur
- Duration: 3 to 5 days
- Reassess at 48 to 72 hours
- Submit samples for culture and susceptibility
Severe Disease Protocol
- First-line options: florfenicol or tulathromycin combined with an NSAID
- Duration: 5 to 7 days
- Reassess at 24 to 48 hours
- Submit samples for culture and susceptibility before treatment
- Consider combination therapy if no response at 48 hours
The study in Veterinary Microbiology examined antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates, providing species-specific guidance for caprine cases.
Step 4: Response Assessment and Decision Points
Assess treatment response at defined intervals and follow the decision tree:
48-Hour Reassessment
- Improved: continue current therapy for full duration
- No change: review culture results if available, consider switching antimicrobial class, extend therapy
- Worsened: switch antimicrobial class immediately, add supportive care, consider diagnostic imaging
72-Hour Reassessment
- Improved: complete therapy course
- No change: switch antimicrobial class based on susceptibility results, extend therapy to 7 days
- Worsened: escalate to veterinary consultation, consider alternative diagnoses
5-Day Reassessment
- Resolved: discontinue therapy, monitor for relapse
- Partial response: extend therapy for 2 to 3 additional days
- No response: veterinary consultation required, consider postmortem examination if death occurs
Step 5: Relapse Management Protocol
Define relapse as recurrence of clinical signs within 14 days of completing therapy. Management protocol:
- Record relapse as treatment failure in herd records
- Collect diagnostic samples before retreatment
- Switch to a different antimicrobial class
- Extend therapy duration to 7 days
- Investigate environmental and management factors
- Consider thoracic ultrasound to assess chronic lesions
Record System for Respiratory Disease Treatment Decisions
A standardized record system enables tracking of treatment outcomes, antimicrobial use, and resistance patterns. The following template captures essential data for each treatment episode:
Individual Animal Treatment Record
| Field | Data Entry |
|---|---|
| Animal ID | Ear tag or tattoo number |
| Date of first treatment | DD/MM/YYYY |
| Age group | Calf, weanling, yearling, adult |
| Production class | Dairy, beef, feedlot, pasture |
| Clinical severity score | Mild, moderate, severe |
| Rectal temperature at diagnosis | Degrees Celsius |
| Respiratory rate at diagnosis | Breaths per minute |
| Thoracic ultrasound findings | Consolidation depth, location |
| Diagnostic samples collected | Swab, BAL, blood, feces |
| Sample submission date | DD/MM/YYYY |
| Antimicrobial used | Drug name and dose |
| Route of administration | IM, SC, IV |
| Duration of therapy | Days |
| NSAID used | Drug name and dose |
| Response at 48 hours | Improved, no change, worsened |
| Response at 72 hours | Improved, no change, worsened |
| Final outcome | Resolved, relapsed, died, culled |
| Withdrawal period end date | DD/MM/YYYY |
| Culture results | Pathogen and susceptibility pattern |
| PCR results | Pathogens detected |
| Veterinarian consulted | Yes or no |
Herd-Level Treatment Summary Table
| Month | Total Animals Treated | Mild Cases | Moderate Cases | Severe Cases | Treatment Success Rate | Relapse Rate | Mortality Rate | Antimicrobial Classes Used |
|---|---|---|---|---|---|---|---|---|
| January | ||||||||
| February | ||||||||
| March | ||||||||
| April | ||||||||
| May | ||||||||
| June | ||||||||
| July | ||||||||
| August | ||||||||
| September | ||||||||
| October | ||||||||
| November | ||||||||
| December |
Antimicrobial Use Monitoring Record
| Antimicrobial Class | Total Doses Used | Number of Treatment Courses | Average Duration (Days) | Number of Relapses | Susceptibility Pattern |
|---|---|---|---|---|---|
| Florfenicol | |||||
| Tulathromycin | |||||
| Ceftiofur | |||||
| Oxytetracycline | |||||
| Tilmicosin | |||||
| Other |
Troubleshooting Method for Treatment Failure
When treatment fails to produce expected improvement within 48 to 72 hours, use the following systematic troubleshooting approach:
Diagnostic Checklist for Treatment Failure
Pathogen-Related Factors
- Was culture and susceptibility testing performed before treatment?
- Is the pathogen resistant to the antimicrobial used?
- Is there a mixed infection with multiple pathogens?
- Is Mycoplasma bovis or Mycoplasma ovipneumoniae involved?
- Is there a viral component that requires supportive care?
Host-Related Factors
- Is the animal immunocompromised due to stress, nutrition, or concurrent disease?
- Is there underlying lungworm infection?
- Is there chronic consolidation or abscess formation?
- Is there pleural effusion or pleuritis?
- Is there concurrent disease such as bovine viral diarrhea virus or parasitism?
Treatment-Related Factors
- Was the correct dose administered?
- Was the route of administration appropriate?
- Was the duration of therapy adequate?
- Was the antimicrobial stored properly?
- Was the withdrawal period observed?
Environmental Factors
- Is ventilation adequate in the housing facility?
- Is stocking density appropriate?
- Is bedding clean and dry?
- Are temperature fluctuations extreme?
- Is there dust or ammonia exposure?
Management Factors
- Were affected animals isolated from healthy animals?
- Is feed and water access adequate?
- Is there ongoing stress from handling or transport?
- Are vaccination protocols current?
Decision Matrix for Treatment Failure Scenarios
| Scenario | Likely Cause | Recommended Action |
|---|---|---|
| No improvement at 48 hours, mild initial signs | Inappropriate antimicrobial selection | Review culture results, switch antimicrobial class |
| No improvement at 48 hours, severe initial signs | Advanced pathology or resistant pathogen | Veterinary consultation, thoracic ultrasound, consider postmortem |
| Improvement then relapse at 5 to 7 days | Inadequate duration or chronic lesion | Extend therapy, investigate for abscess or sequestrum |
| Worsening at 24 hours | Wrong diagnosis or fulminant infection | Veterinary consultation, diagnostic imaging, postmortem |
| Multiple animals failing same protocol | Herd-level resistance or environmental factor | Review culture results, investigate ventilation and management |
| Chronic cough persisting after treatment | Lungworm, Mycoplasma, or chronic pneumonia | Fecal Baermann, Mycoplasma PCR, thoracic ultrasound |
Comparison of Diagnostic Approaches Across Ruminant Species
The diagnostic approach for respiratory disease varies by species due to differences in anatomy, common pathogens, and practical constraints. The following comparison guides species-specific decision making:
Diagnostic Method Comparison
| Diagnostic Method | Cattle | Sheep | Goats |
|---|---|---|---|
| Clinical scoring systems | Wisconsin calf score, DART system validated | Limited validated scoring systems | No standardized scoring system |
| Thoracic ultrasound | Well-established, practical in calves and feedlot cattle | Feasible in lambs and adults | Feasible in adults, limited reference values |
| Nasopharyngeal swab culture | Standard practice, good sensitivity | Standard practice | Standard practice |
| Bronchoalveolar lavage | Feasible in standing cattle | Feasible under sedation | Feasible under sedation |
| Fecal Baermann | Useful for Dictyocaulus viviparus | Essential for lungworm diagnosis | Essential for lungworm diagnosis |
| PCR panels | Commercially available for BRD pathogens | Limited commercial panels | Limited commercial panels |
| Serology | Useful for herd-level diagnosis | Limited utility for individual cases | Limited utility for individual cases |
| Postmortem examination | Standard protocol | Standard protocol | Standard protocol |
Pathogen Prevalence Comparison
| Pathogen | Cattle | Sheep | Goats |
|---|---|---|---|
| Mannheimia haemolytica | Common | Common | Common |
| Pasteurella multocida | Common | Common | Common |
| Histophilus somni | Common | Rare | Rare |
| Mycoplasma bovis | Common | Rare | Rare |
| Mycoplasma ovipneumoniae | Rare | Common | Common |
| Bibersteinia trehalosi | Rare | Common | Rare |
| Escherichia coli | Uncommon | Uncommon | Reported in respiratory disease |
| BRSV | Common | Rare | Rare |
| PI-3 | Common | Common | Common |
| BHV-1 | Common | Rare | Rare |
| Lungworm | Dictyocaulus viviparus | Dictyocaulus filaria, Muellerius capillaris | Muellerius capillaris, Protostrongylus |
The study in Microbial Pathogenesis reported molecular characterization and antimicrobial resistance profile of pathogenic Escherichia coli from goats with respiratory disease in eastern China, highlighting this pathogen's role in caprine respiratory infections.
Treatment Protocol Comparison
| Treatment Aspect | Cattle | Sheep | Goats |
|---|---|---|---|
| First-line antimicrobial | Tulathromycin, florfenicol | Oxytetracycline, florfenicol | Oxytetracycline, tulathromycin |
| Second-line antimicrobial | Ceftiofur, tilmicosin | Tulathromycin, ceftiofur | Florfenicol, ceftiofur |
| NSAID use | Flunixin meglumine, meloxicam | Meloxicam, flunixin meglumine | Meloxicam, flunixin meglumine |
| Anthelmintic for lungworm | Ivermectin, doramectin | Ivermectin, moxidectin | Ivermectin, fenbendazole |
| Withdrawal period variation | Species-specific labels | Species-specific labels | Species-specific labels |
| Vaccine availability | Multiple commercial options | Limited commercial options | Limited commercial options |
The study in BMC Microbiology characterized Mesomycoplasma ovipneumoniae from goats with respiratory infection, emphasizing the importance of species-specific pathogen identification for treatment decisions.
Practical Implementation Steps for the Decision Framework
Week 1 Implementation
- Train all personnel on clinical severity classification using the three-tier system
- Print and distribute the treatment decision algorithm
- Establish diagnostic sample collection protocols and supply collection materials
- Create individual animal treatment record forms
- Designate a treatment record keeper
Month 1 Implementation
- Implement the record system for all respiratory disease treatments
- Submit diagnostic samples for at least 10 treatment episodes
- Review culture and susceptibility results with veterinarian
- Calculate initial treatment success rate
- Identify any protocol deviations
Quarter 1 Implementation
- Analyze herd-level treatment summary data
- Compare treatment outcomes across severity categories
- Review antimicrobial use patterns
- Adjust empirical protocols based on susceptibility data
- Present findings to veterinary consultant
Annual Implementation
- Conduct comprehensive review of respiratory disease management
- Update treatment protocols based on resistance trends
- Evaluate vaccination program effectiveness
- Assess environmental and management risk factors
- Plan preventive interventions for high-risk periods
Common Failure Patterns in Decision Framework Application
Failure Pattern 1: Inconsistent Severity Classification
Different personnel may classify the same animal differently, leading to inconsistent treatment decisions. Standardize training using video examples and live animal demonstrations. Conduct periodic inter-observer reliability checks. Use objective criteria such as rectal temperature thresholds and respiratory rate cutoffs.
Failure Pattern 2: Delayed Diagnostic Sampling
Waiting for culture results before initiating treatment in moderate or severe cases can worsen outcomes. Collect samples immediately at diagnosis and start empirical therapy. Adjust therapy when results become available. The systematic review in the Veterinary Clinics of North America Food Animal Practice focused on diagnostic confirmation, early detection, and prediction of unfavorable outcomes in feedlot cattle.
Failure Pattern 3: Incomplete Record Keeping
Missing treatment records prevent outcome analysis and antimicrobial use monitoring. Assign record-keeping responsibility to one person per shift. Use pre-printed forms with checkboxes to reduce writing burden. Review records weekly for completeness.
Failure Pattern 4: Failure to Adjust Protocols Based on Data
Continuing the same empirical protocol despite poor treatment outcomes wastes resources and promotes resistance. Schedule quarterly protocol reviews with veterinary input. Track treatment success rates by antimicrobial class. Change protocols when success rate falls below 70 percent.
Failure Pattern 5: Ignoring Environmental Factors
Treating respiratory disease without addressing underlying environmental stressors leads to high relapse rates. Include environmental assessment in every treatment episode. Document ventilation, stocking density, and bedding quality. Implement corrective actions before the next high-risk period.
Welfare and Safety Context for Decision Framework
Animal Welfare Implications
The decision framework prioritizes prompt treatment based on severity classification, reducing the duration of pain and respiratory distress. Mild cases receive early intervention before progression to moderate or severe disease. The framework includes NSAID use for fever and inflammation, addressing pain associated with pneumonia. The World Organisation for Animal Health provides standards for animal welfare in livestock production.
Human Safety Considerations
Personnel implementing the decision framework must handle affected animals and diagnostic samples. Use gloves when collecting nasopharyngeal swabs and handling fecal samples. Wear eye protection when performing bronchoalveolar lavage. Practice hand hygiene after animal contact. The Merck Veterinary Manual provides guidance on zoonotic pathogens associated with ruminant respiratory disease.
Regulatory Compliance
All antimicrobial use must comply with local regulations regarding prescription requirements and withdrawal periods. Record all treatments including drug, dose, route, date, and withdrawal period. The World Organisation for Animal Health provides guidelines for antimicrobial use in animals.
Professional Escalation Criteria Specific to Decision Framework
Urgent Veterinary Escalation
Contact a veterinarian immediately if:
- More than 20 percent of treated animals show no improvement at 48 hours
- More than 10 percent of treated animals worsen within 24 hours
- Relapse rate exceeds 25 percent in any treatment group
- Postmortem examination reveals unexpected pathology
- Suspected antimicrobial resistance to multiple drug classes
Routine Veterinary Consultation
Schedule a veterinary consultation if:
- Quarterly treatment success rate falls below 70 percent
- Antimicrobial use patterns show increasing reliance on a single class
- Culture results show resistance to first-line antimicrobials
- Herd-level respiratory disease incidence exceeds 15 percent
- New pathogens are identified through diagnostic testing
Frequently Asked Questions
What are the most common causes of respiratory disease in cattle?
The most common causes of bovine respiratory disease (BRD) are viral pathogens including bovine respiratory syncytial virus (BRSV), parainfluenza-3 virus (PI-3), bovine herpesvirus-1 (BHV-1), and bovine viral diarrhea virus (BVDV), and bacterial pathogens including Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. Environmental stressors such as weaning, transport, and poor ventilation predispose animals to disease. The Merck Veterinary Manual provides detailed information on BRD etiology.
How is bovine respiratory disease diagnosed in feedlot cattle?
BRD in feedlot cattle is diagnosed using clinical scoring systems such as the DART (Depression, Appetite, Respiration, Temperature) system, daily observation by trained pen riders, thoracic ultrasound, and laboratory confirmation through nasopharyngeal swab culture and PCR. A systematic review in the Veterinary Clinics of North America: Food Animal Practice focused on diagnostic confirmation, early detection, and prediction of unfavorable outcomes in feedlot cattle.
What is the role of Mycoplasma ovipneumoniae in caprine respiratory disease?
Mycoplasma ovipneumoniae is a primary pathogen in goats, causing chronic cough, reduced growth rates, and increased susceptibility to secondary bacterial infections. A study in BMC Microbiology characterized the pathogenic characteristics, population structure, and genomic features of Mesomycoplasma ovipneumoniae from goats with respiratory infection.
How is lungworm diagnosed in sheep and goats?
Lungworm is diagnosed using the fecal Baermann examination, which detects larvae in feces. Clinical signs include cough, tachypnea, dyspnea, weight loss, and reduced exercise tolerance. Postmortem examination reveals adult worms in the airways and characteristic lung lesions. The Merck Veterinary Manual provides detailed information on lungworm diagnosis.
What antimicrobials are commonly used for respiratory disease in goats?
Commonly used antimicrobials for caprine respiratory infections include oxytetracycline, florfenicol, tulathromycin, and ceftiofur. Antimicrobial selection should be based on culture and susceptibility results. A study in Veterinary Microbiology examined antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates.
How can respiratory disease be prevented in ruminants?
Prevention of respiratory disease in ruminants focuses on reducing stress, optimizing nutrition, implementing vaccination programs, and maintaining good biosecurity. Vaccines are available for viral and bacterial pathogens. Biosecurity measures include quarantine of new arrivals, all-in/all-out management, and proper ventilation in housing facilities. The World Organisation for Animal Health provides guidelines for animal health and welfare.
What is the importance of antimicrobial stewardship in respiratory disease treatment?
Antimicrobial stewardship is critical to preserve the effectiveness of antimicrobials and reduce the development of resistance. Culture and antimicrobial susceptibility testing should guide treatment decisions. Withdrawal periods must be observed to ensure food safety. The World Organisation for Animal Health provides guidelines for responsible antimicrobial use in animals.
When should a veterinarian be contacted for respiratory disease in ruminants?
A veterinarian should be contacted urgently if multiple animals are affected with severe respiratory signs, mortality rate exceeds 2% in a group, treatment failure occurs in more than 20% of treated animals, or suspected contagious disease. Routine veterinary consultation is recommended if respiratory disease incidence exceeds 10% in a group, relapse rate exceeds 15%, or chronic cough persists.
Related Veterinary Guides
- Beef Cattle Respiratory Disease Risk Reduction
- Goat Health Management Vaccination Biosecurity Disease Prevention
- Beef Cow Pregnancy Diagnosis Records
- Sheep Foot Health And Lameness Prevention
- Veterinary Clinical Methods Procedures Surgical Interventions
References and Further Reading
- www.acvim.org
- Merck Veterinary Manual. Merck Veterinary Manual.
- Animal Health and Welfare. World Organisation for Animal Health.
- Bovine Respiratory Disease Diagnosis: What Progress Has Been Made in Clinical Diagnosis?. The Veterinary clinics of North America. Food animal practice, 2020.
- Bovine Respiratory Disease Considerations in Young Dairy Calves.. The Veterinary clinics of North America. Food animal practice, 2022.
- Laboratory and postmortem diagnosis of bovine respiratory disease.. The Veterinary clinics of North America. Food animal practice, 2012.
- A systematic review of the utility of biomarkers as aids in the early diagnosis and outcome prediction of bovine respiratory disease complex in feedlot cattle.. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 2022.
- Bovine respiratory coronavirus.. The Veterinary clinics of North America. Food animal practice, 2010.
- A Systematic Review of Bovine Respiratory Disease Diagnosis Focused on Diagnostic Confirmation, Early Detection, and Prediction of Unfavorable Outcomes in Feedlot Cattle.. The Veterinary clinics of North America. Food animal practice, 2015.
- Antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates. Veterinary Microbiology, 2012.
- Mesomycoplasma ovipneumoniae from goats with respiratory infection: pathogenic characteristics, population structure, and genomic features. BMC Microbiology, 2023.
- Molecular characterization and antimicrobial resistance profile of pathogenic Escherichia coli from goats with respiratory disease in eastern China. Microbial Pathogenesis, 2022.
This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.